Creative Diagnostics Launches Respiratory Syncytial Virus Animal Model Services for Antiviral and Vaccine Discovery

▤ Summary

Creative Diagnostics has expanded its preclinical portfolio with respiratory syncytial virus animal model services. The new offering supports antiviral, antibody, and vaccine discovery by giving researchers tailored in vivo systems for evaluating efficacy, toxicity, immune response, and pharmacokinetics. The service targets a known gap in RSV research, where existing animal models only partially replicate human infection. This launch gives biopharma and academic teams a new option for preclinical validation and model selection support.

▦ Linked Companies